 | • レポートコード：MRC2-11QY09307 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、115ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は統合失調症治療薬のグローバル市場について調査・分析したレポートです。種類別（経口抗精神病治療薬、注射用抗精神病治療薬）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別統合失調症治療薬の競争状況、市場シェア ・世界の統合失調症治療薬市場：種類別市場規模 2015年-2020年（経口抗精神病治療薬、注射用抗精神病治療薬） ・世界の統合失調症治療薬市場：種類別市場規模予測 2021年-2026年（経口抗精神病治療薬、注射用抗精神病治療薬） ・世界の統合失調症治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の統合失調症治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の統合失調症治療薬市場分析：米国、カナダ ・ヨーロッパの統合失調症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの統合失調症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の統合失調症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの統合失調症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Johnson & Johnson、Bristol-Myers Squibb、Otsuka Pharma、AstraZeneca、Sumitomo Dainippon、Eli Lilly、Alkermes、Vanda Pharma、Allergan、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Schizophrenia Drugs Market
The global Schizophrenia Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Schizophrenia Drugs Scope and Market Size
Schizophrenia Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Schizophrenia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Schizophrenia Drugs market is segmented into
Oral Antipsychotics
Injectable Antipsychotics
Segment by Application, the Schizophrenia Drugs market is segmented into
Hospital
Clinic
Regional and Country-level Analysis
The Schizophrenia Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Schizophrenia Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Schizophrenia Drugs Market Share Analysis
Schizophrenia Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Schizophrenia Drugs business, the date to enter into the Schizophrenia Drugs market, Schizophrenia Drugs product introduction, recent developments, etc.
The major vendors covered:
Johnson & Johnson
Bristol-Myers Squibb
Otsuka Pharma
AstraZeneca
Sumitomo Dainippon
Eli Lilly
Alkermes
Vanda Pharma
Allergan
Pfizer
1 Study Coverage
1.1 Schizophrenia Drugs Product Introduction
1.2 Market Segments
1.3 Key Schizophrenia Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Schizophrenia Drugs Market Size Growth Rate by Type
1.4.2 Oral Antipsychotics
1.4.3 Injectable Antipsychotics
1.5 Market by Application
1.5.1 Global Schizophrenia Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Schizophrenia Drugs Market Size, Estimates and Forecasts
2.1.1 Global Schizophrenia Drugs Revenue 2015-2026
2.1.2 Global Schizophrenia Drugs Sales 2015-2026
2.2 Global Schizophrenia Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Schizophrenia Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Schizophrenia Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Schizophrenia Drugs Competitor Landscape by Players
3.1 Schizophrenia Drugs Sales by Manufacturers
3.1.1 Schizophrenia Drugs Sales by Manufacturers (2015-2020)
3.1.2 Schizophrenia Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Schizophrenia Drugs Revenue by Manufacturers
3.2.1 Schizophrenia Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Schizophrenia Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Schizophrenia Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Schizophrenia Drugs Revenue in 2019
3.2.5 Global Schizophrenia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Schizophrenia Drugs Price by Manufacturers
3.4 Schizophrenia Drugs Manufacturing Base Distribution, Product Types
3.4.1 Schizophrenia Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Schizophrenia Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Schizophrenia Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Schizophrenia Drugs Market Size by Type (2015-2020)
4.1.1 Global Schizophrenia Drugs Sales by Type (2015-2020)
4.1.2 Global Schizophrenia Drugs Revenue by Type (2015-2020)
4.1.3 Schizophrenia Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Schizophrenia Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Schizophrenia Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Schizophrenia Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Schizophrenia Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Schizophrenia Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Schizophrenia Drugs Market Size by Application (2015-2020)
5.1.1 Global Schizophrenia Drugs Sales by Application (2015-2020)
5.1.2 Global Schizophrenia Drugs Revenue by Application (2015-2020)
5.1.3 Schizophrenia Drugs Price by Application (2015-2020)
5.2 Schizophrenia Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Schizophrenia Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Schizophrenia Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Schizophrenia Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Schizophrenia Drugs by Country
6.1.1 North America Schizophrenia Drugs Sales by Country
6.1.2 North America Schizophrenia Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Schizophrenia Drugs Market Facts & Figures by Type
6.3 North America Schizophrenia Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Schizophrenia Drugs by Country
7.1.1 Europe Schizophrenia Drugs Sales by Country
7.1.2 Europe Schizophrenia Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Schizophrenia Drugs Market Facts & Figures by Type
7.3 Europe Schizophrenia Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Schizophrenia Drugs by Region
8.1.1 Asia Pacific Schizophrenia Drugs Sales by Region
8.1.2 Asia Pacific Schizophrenia Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Schizophrenia Drugs Market Facts & Figures by Type
8.3 Asia Pacific Schizophrenia Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Schizophrenia Drugs by Country
9.1.1 Latin America Schizophrenia Drugs Sales by Country
9.1.2 Latin America Schizophrenia Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Schizophrenia Drugs Market Facts & Figures by Type
9.3 Central & South America Schizophrenia Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Schizophrenia Drugs by Country
10.1.1 Middle East and Africa Schizophrenia Drugs Sales by Country
10.1.2 Middle East and Africa Schizophrenia Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Schizophrenia Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Schizophrenia Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Schizophrenia Drugs Products Offered
11.1.5 Johnson & Johnson Related Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Corporation Information
11.2.2 Bristol-Myers Squibb Description and Business Overview
11.2.3 Bristol-Myers Squibb Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Bristol-Myers Squibb Schizophrenia Drugs Products Offered
11.2.5 Bristol-Myers Squibb Related Developments
11.3 Otsuka Pharma
11.3.1 Otsuka Pharma Corporation Information
11.3.2 Otsuka Pharma Description and Business Overview
11.3.3 Otsuka Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Otsuka Pharma Schizophrenia Drugs Products Offered
11.3.5 Otsuka Pharma Related Developments
11.4 AstraZeneca
11.4.1 AstraZeneca Corporation Information
11.4.2 AstraZeneca Description and Business Overview
11.4.3 AstraZeneca Sales, Revenue and Gross Margin (2015-2020)
11.4.4 AstraZeneca Schizophrenia Drugs Products Offered
11.4.5 AstraZeneca Related Developments
11.5 Sumitomo Dainippon
11.5.1 Sumitomo Dainippon Corporation Information
11.5.2 Sumitomo Dainippon Description and Business Overview
11.5.3 Sumitomo Dainippon Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Sumitomo Dainippon Schizophrenia Drugs Products Offered
11.5.5 Sumitomo Dainippon Related Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Corporation Information
11.6.2 Eli Lilly Description and Business Overview
11.6.3 Eli Lilly Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Eli Lilly Schizophrenia Drugs Products Offered
11.6.5 Eli Lilly Related Developments
11.7 Alkermes
11.7.1 Alkermes Corporation Information
11.7.2 Alkermes Description and Business Overview
11.7.3 Alkermes Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Alkermes Schizophrenia Drugs Products Offered
11.7.5 Alkermes Related Developments
11.8 Vanda Pharma
11.8.1 Vanda Pharma Corporation Information
11.8.2 Vanda Pharma Description and Business Overview
11.8.3 Vanda Pharma Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Vanda Pharma Schizophrenia Drugs Products Offered
11.8.5 Vanda Pharma Related Developments
11.9 Allergan
11.9.1 Allergan Corporation Information
11.9.2 Allergan Description and Business Overview
11.9.3 Allergan Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Allergan Schizophrenia Drugs Products Offered
11.9.5 Allergan Related Developments
11.10 Pfizer
11.10.1 Pfizer Corporation Information
11.10.2 Pfizer Description and Business Overview
11.10.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Pfizer Schizophrenia Drugs Products Offered
11.10.5 Pfizer Related Developments
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Corporation Information
11.1.2 Johnson & Johnson Description and Business Overview
11.1.3 Johnson & Johnson Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Johnson & Johnson Schizophrenia Drugs Products Offered
11.1.5 Johnson & Johnson Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Schizophrenia Drugs Market Estimates and Projections by Region
12.1.1 Global Schizophrenia Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Schizophrenia Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Schizophrenia Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Schizophrenia Drugs Sales Forecast (2021-2026)
12.2.2 North America: Schizophrenia Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Schizophrenia Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Schizophrenia Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Schizophrenia Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Schizophrenia Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Schizophrenia Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Schizophrenia Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Schizophrenia Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Schizophrenia Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Schizophrenia Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Schizophrenia Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Schizophrenia Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Schizophrenia Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Schizophrenia Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Schizophrenia Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Schizophrenia Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Schizophrenia Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Schizophrenia Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Schizophrenia Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Schizophrenia Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Schizophrenia Drugs Market Segments
Table 2. Ranking of Global Top Schizophrenia Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Schizophrenia Drugs Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)
Table 4. Major Manufacturers of Oral Antipsychotics
Table 5. Major Manufacturers of Injectable Antipsychotics
Table 6. Global Schizophrenia Drugs Market Size Growth Rate by Application 2020-2026 (K Units)
Table 7. Global Schizophrenia Drugs Market Size by Region (K Units) & (US$ Million): 2020 VS 2026
Table 8. Global Schizophrenia Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Schizophrenia Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Schizophrenia Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Schizophrenia Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 12. Global Schizophrenia Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Schizophrenia Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Schizophrenia Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Schizophrenia Drugs as of 2019)
Table 15. Schizophrenia Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Schizophrenia Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Schizophrenia Drugs Price (2015-2020) (US$/Unit)
Table 18. Schizophrenia Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Schizophrenia Drugs Product Type
Table 20. Date of International Manufacturers Enter into Schizophrenia Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Schizophrenia Drugs Sales by Type (2015-2020) (K Units)
Table 23. Global Schizophrenia Drugs Sales Share by Type (2015-2020)
Table 24. Global Schizophrenia Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Schizophrenia Drugs Revenue Share by Type (2015-2020)
Table 26. Schizophrenia Drugs Average Selling Price (ASP) by Type 2015-2020 (US$/Unit)
Table 27. Global Schizophrenia Drugs Sales by Application (2015-2020) (K Units)
Table 28. Global Schizophrenia Drugs Sales Share by Application (2015-2020)
Table 29. North America Schizophrenia Drugs Sales by Country (2015-2020) (K Units)
Table 30. North America Schizophrenia Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Schizophrenia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Schizophrenia Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Schizophrenia Drugs Sales by Type (2015-2020) (K Units)
Table 34. North America Schizophrenia Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Schizophrenia Drugs Sales by Application (2015-2020) (K Units)
Table 36. North America Schizophrenia Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Schizophrenia Drugs Sales by Country (2015-2020) (K Units)
Table 38. Europe Schizophrenia Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Schizophrenia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Schizophrenia Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Schizophrenia Drugs Sales by Type (2015-2020) (K Units)
Table 42. Europe Schizophrenia Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Schizophrenia Drugs Sales by Application (2015-2020) (K Units)
Table 44. Europe Schizophrenia Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Schizophrenia Drugs Sales by Region (2015-2020) (K Units)
Table 46. Asia Pacific Schizophrenia Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Schizophrenia Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Schizophrenia Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Schizophrenia Drugs Sales by Type (2015-2020) (K Units)
Table 50. Asia Pacific Schizophrenia Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Schizophrenia Drugs Sales by Application (2015-2020) (K Units)
Table 52. Asia Pacific Schizophrenia Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Schizophrenia Drugs Sales by Country (2015-2020) (K Units)
Table 54. Latin America Schizophrenia Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Schizophrenia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Schizophrenia Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Schizophrenia Drugs Sales by Type (2015-2020) (K Units)
Table 58. Latin America Schizophrenia Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Schizophrenia Drugs Sales by Application (2015-2020) (K Units)
Table 60. Latin America Schizophrenia Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Schizophrenia Drugs Sales by Country (2015-2020) (K Units)
Table 62. Middle East and Africa Schizophrenia Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Schizophrenia Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Schizophrenia Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Schizophrenia Drugs Sales by Type (2015-2020) (K Units)
Table 66. Middle East and Africa Schizophrenia Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Schizophrenia Drugs Sales by Application (2015-2020) (K Units)
Table 68. Middle East and Africa Schizophrenia Drugs Sales Market Share by Application (2015-2020)
Table 69. Johnson & Johnson Corporation Information
Table 70. Johnson & Johnson Description and Major Businesses
Table 71. Johnson & Johnson Schizophrenia Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 72. Johnson & Johnson Product
Table 73. Johnson & Johnson Recent Development
Table 74. Bristol-Myers Squibb Corporation Information
Table 75. Bristol-Myers Squibb Description and Major Businesses
Table 76. Bristol-Myers Squibb Schizophrenia Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 77. Bristol-Myers Squibb Product
Table 78. Bristol-Myers Squibb Recent Development
Table 79. Otsuka Pharma Corporation Information
Table 80. Otsuka Pharma Description and Major Businesses
Table 81. Otsuka Pharma Schizophrenia Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 82. Otsuka Pharma Product
Table 83. Otsuka Pharma Recent Development
Table 84. AstraZeneca Corporation Information
Table 85. AstraZeneca Description and Major Businesses
Table 86. AstraZeneca Schizophrenia Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 87. AstraZeneca Product
Table 88. AstraZeneca Recent Development
Table 89. Sumitomo Dainippon Corporation Information
Table 90. Sumitomo Dainippon Description and Major Businesses
Table 91. Sumitomo Dainippon Schizophrenia Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 92. Sumitomo Dainippon Product
Table 93. Sumitomo Dainippon Recent Development
Table 94. Eli Lilly Corporation Information
Table 95. Eli Lilly Description and Major Businesses
Table 96. Eli Lilly Schizophrenia Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 97. Eli Lilly Product
Table 98. Eli Lilly Recent Development
Table 99. Alkermes Corporation Information
Table 100. Alkermes Description and Major Businesses
Table 101. Alkermes Schizophrenia Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 102. Alkermes Product
Table 103. Alkermes Recent Development
Table 104. Vanda Pharma Corporation Information
Table 105. Vanda Pharma Description and Major Businesses
Table 106. Vanda Pharma Schizophrenia Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 107. Vanda Pharma Product
Table 108. Vanda Pharma Recent Development
Table 109. Allergan Corporation Information
Table 110. Allergan Description and Major Businesses
Table 111. Allergan Schizophrenia Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 112. Allergan Product
Table 113. Allergan Recent Development
Table 114. Pfizer Corporation Information
Table 115. Pfizer Description and Major Businesses
Table 116. Pfizer Schizophrenia Drugs Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 117. Pfizer Product
Table 118. Pfizer Recent Development
Table 119. Global Schizophrenia Drugs Sales Forecast by Regions (2021-2026) (K Units)
Table 120. Global Schizophrenia Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 121. Global Schizophrenia Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 122. Global Schizophrenia Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 123. North America: Schizophrenia Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 124. North America: Schizophrenia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 125. Europe: Schizophrenia Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 126. Europe: Schizophrenia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 127. Asia Pacific: Schizophrenia Drugs Sales Forecast by Region (2021-2026) (K Units)
Table 128. Asia Pacific: Schizophrenia Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 129. Latin America: Schizophrenia Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 130. Latin America: Schizophrenia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 131. Middle East and Africa: Schizophrenia Drugs Sales Forecast by Country (2021-2026) (K Units)
Table 132. Middle East and Africa: Schizophrenia Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 133. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 134. Key Challenges
Table 135. Market Risks
Table 136. Main Points Interviewed from Key Schizophrenia Drugs Players
Table 137. Schizophrenia Drugs Customers List
Table 138. Schizophrenia Drugs Distributors List
Table 139. Research Programs/Design for This Report
Table 140. Key Data Information from Secondary Sources
Table 141. Key Data Information from Primary Sources
List of Figures
Figure 1. Schizophrenia Drugs Product Picture
Figure 2. Global Schizophrenia Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Antipsychotics Product Picture
Figure 4. Injectable Antipsychotics Product Picture
Figure 5. Global Schizophrenia Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Schizophrenia Drugs Report Years Considered
Figure 9. Global Schizophrenia Drugs Market Size 2015-2026 (US$ Million)
Figure 10. Global Schizophrenia Drugs Sales 2015-2026 (K Units)
Figure 11. Global Schizophrenia Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Global Schizophrenia Drugs Sales Market Share by Region (2015-2020)
Figure 13. Global Schizophrenia Drugs Sales Market Share by Region in 2019
Figure 14. Global Schizophrenia Drugs Revenue Market Share by Region (2015-2020)
Figure 15. Global Schizophrenia Drugs Revenue Market Share by Region in 2019
Figure 16. Global Schizophrenia Drugs Sales Share by Manufacturer in 2019
Figure 17. The Top 10 and 5 Players Market Share by Schizophrenia Drugs Revenue in 2019
Figure 18. Schizophrenia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 19. Global Schizophrenia Drugs Sales Market Share by Type (2015-2020)
Figure 20. Global Schizophrenia Drugs Sales Market Share by Type in 2019
Figure 21. Global Schizophrenia Drugs Revenue Market Share by Type (2015-2020)
Figure 22. Global Schizophrenia Drugs Revenue Market Share by Type in 2019
Figure 23. Global Schizophrenia Drugs Market Share by Price Range (2015-2020)
Figure 24. Global Schizophrenia Drugs Sales Market Share by Application (2015-2020)
Figure 25. Global Schizophrenia Drugs Sales Market Share by Application in 2019
Figure 26. Global Schizophrenia Drugs Revenue Market Share by Application (2015-2020)
Figure 27. Global Schizophrenia Drugs Revenue Market Share by Application in 2019
Figure 28. North America Schizophrenia Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 29. North America Schizophrenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 30. North America Schizophrenia Drugs Sales Market Share by Country in 2019
Figure 31. North America Schizophrenia Drugs Revenue Market Share by Country in 2019
Figure 32. U.S. Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. U.S. Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Canada Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 35. Canada Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. North America Schizophrenia Drugs Market Share by Type in 2019
Figure 37. North America Schizophrenia Drugs Market Share by Application in 2019
Figure 38. Europe Schizophrenia Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 39. Europe Schizophrenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 40. Europe Schizophrenia Drugs Sales Market Share by Country in 2019
Figure 41. Europe Schizophrenia Drugs Revenue Market Share by Country in 2019
Figure 42. Germany Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Germany Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. France Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. France Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. U.K. Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 47. U.K. Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Italy Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Italy Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Russia Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 51. Russia Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Europe Schizophrenia Drugs Market Share by Type in 2019
Figure 53. Europe Schizophrenia Drugs Market Share by Application in 2019
Figure 54. Asia Pacific Schizophrenia Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 55. Asia Pacific Schizophrenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 56. Asia Pacific Schizophrenia Drugs Sales Market Share by Region in 2019
Figure 57. Asia Pacific Schizophrenia Drugs Revenue Market Share by Region in 2019
Figure 58. China Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 59. China Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Japan Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 61. Japan Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. South Korea Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 63. South Korea Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. India Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 65. India Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Australia Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 67. Australia Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Taiwan Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 69. Taiwan Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Indonesia Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 71. Indonesia Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Thailand Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 73. Thailand Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Malaysia Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 75. Malaysia Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Philippines Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 77. Philippines Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Vietnam Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 79. Vietnam Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Asia Pacific Schizophrenia Drugs Market Share by Type in 2019
Figure 81. Asia Pacific Schizophrenia Drugs Market Share by Application in 2019
Figure 82. Latin America Schizophrenia Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 83. Latin America Schizophrenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 84. Latin America Schizophrenia Drugs Sales Market Share by Country in 2019
Figure 85. Latin America Schizophrenia Drugs Revenue Market Share by Country in 2019
Figure 86. Mexico Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 87. Mexico Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 88. Brazil Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 89. Brazil Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Argentina Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 91. Argentina Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Latin America Schizophrenia Drugs Market Share by Type in 2019
Figure 93. Latin America Schizophrenia Drugs Market Share by Application in 2019
Figure 94. Middle East and Africa Schizophrenia Drugs Sales Growth Rate 2015-2020 (K Units)
Figure 95. Middle East and Africa Schizophrenia Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 96. Middle East and Africa Schizophrenia Drugs Sales Market Share by Country in 2019
Figure 97. Middle East and Africa Schizophrenia Drugs Revenue Market Share by Country in 2019
Figure 98. Turkey Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 99. Turkey Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 100. Saudi Arabia Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 101. Saudi Arabia Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. UAE Schizophrenia Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 103. UAE Schizophrenia Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. Middle East and Africa Schizophrenia Drugs Market Share by Type in 2019
Figure 105. Middle East and Africa Schizophrenia Drugs Market Share by Application in 2019
Figure 106. North America Schizophrenia Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 107. North America Schizophrenia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 108. Europe Schizophrenia Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 109. Europe Schizophrenia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Asia Pacific Schizophrenia Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 111. Asia Pacific Schizophrenia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Latin America Schizophrenia Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 113. Latin America Schizophrenia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Middle East and Africa Schizophrenia Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 115. Middle East and Africa Schizophrenia Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Porter's Five Forces Analysis
Figure 117. Channels of Distribution
Figure 118. Distributors Profiles
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed
統合失調症治療の世界市場（～2026年） Schizophrenia is a mental disorder characterized by abnormal behavior and failure to understand reality. The schizophrenia treatment market is expected to witness a high growth over the forecast period owing to the increasing incidence of schizophrenia. Market Analysis and Insights: Global Schizophr…- 病院用注射薬の世界市場（～2026年） Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body. Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such a…
- 精神障害薬の世界市場（～2026年） Market Analysis and Insights: Global Mental Disorders Drugs Market The global Mental Disorders Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Mental Disorders Drugs Scope and Market Size Mental Disorders Drugs m…
- 注射薬の世界市場（～2026年） Drug injection is a method of introducing a drug into the bloodstream via a hollow hypodermic needle and a syringe, which is pierced through the skin into the body. Injectable drugs bypasses first-pass metabolism in the liver, resulting in higher bioavailability and efficiency for many drugs (such a…
- 抗精神病薬の世界市場（～2026年） Antipsychotics, also known as neuroleptics or major tranquilizers, are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. During 2016, the second-generation antipsychotic d…